glp-1 and breast cancer risk Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence Study links GLP-1 drugs to
Description
Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2

They are GREAT people to work with

Still Undecided

While GLP-1s are not magic, they often help the body act more like its younger self

Do not be that patient
Trends in GLP-1 use From 2015 to 2024, GLP-1 uptake after an index event in patients with diabetes increased modestly but remained low
